Related Experiment Video
Updated: Oct 8, 2025

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
Published on: August 12, 2015
CPEB4 Inhibit Cell Proliferation via Upregulating p21 mRNA Stability in Renal Cell Carcinoma
Jiehui Di1,2,3, Hui Wang1,2,3, Zhongjun Zhao1,2,3
1Cancer Institute, Xuzhou Medical University, Xuzhou, China.
Abstract:
Cytoplasmic polyadenylation element-binding protein 4 (CPEB4) has been reported to be dysregulated in a variety of cancers and seems to play paradoxical roles in different cancers. However, the functional roles of CPEB4 in Renal cell carcinoma (RCC) are still unclear. This study aims to explore the role and underlying mechanism of CPEB4 in RCC. We found that the relative expression level of CPEB4 is down-regulated in RCC tissues and cell lines, and the low CPEB4 expression is correlated with short overall and disease-free survival of RCC patients. CPEB4 significantly inhibits RCC tumor growth both in vivo and in vitro. CPEB4 exerts an anti-tumor effect by increasing p21 mRNA stability and inducing G1 cell cycle arrest in RCC. Our data revealed that CPEB4 is a tumor suppressor gene that restrains cell cycle progression upstream of p21 in RCC. These findings revealed that CPEB4 may become a promising predictive biomarker for prognosis in patients with RCC.
Insights
Cytoplasmic polyadenylation element-binding protein 4 (CPEB4) acts as a tumor suppressor in renal cell carcinoma (RCC). Low CPEB4 expression correlates with poor prognosis, and it inhibits RCC growth by regulating cell cycle progression.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cytoplasmic polyadenylation element-binding protein 4 (CPEB4) exhibits varied roles across different cancers.
- The specific function of CPEB4 in renal cell carcinoma (RCC) remains largely undetermined.
Purpose of the Study:
- To investigate the role and molecular mechanisms of CPEB4 in the development and progression of RCC.
- To evaluate CPEB4 as a potential prognostic biomarker in RCC patients.
Main Methods:
- Analysis of CPEB4 expression levels in RCC tissues and cell lines.
- In vivo and in vitro experiments to assess the impact of CPEB4 on RCC tumor growth.
- Investigation of CPEB4's effect on p21 mRNA stability and cell cycle regulation.
Main Results:
- CPEB4 expression is significantly down-regulated in RCC tissues and cell lines.
- Lower CPEB4 expression is associated with reduced overall and disease-free survival in RCC patients.
- CPEB4 demonstrates potent inhibition of RCC tumor growth and induces G1 cell cycle arrest by enhancing p21 mRNA stability.
Conclusions:
- CPEB4 functions as a tumor suppressor gene in RCC, restraining cell cycle progression upstream of p21.
- CPEB4 holds promise as a predictive biomarker for prognosis in patients with renal cell carcinoma.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Inhibition of Cdk Activity
Cell Specific Gene Expression
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

